Back to results
US 2006/0135608 A1Published application
Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia
OwnerDavid Horrobin, Agnes Ayton +1inventors
InventorsDavid Horrobin, Agnes Ayton, Sherri Clarkson
Life of this patent
Estimating the term…
Abstract
Eicosapentaenoic acid (EPA) is used in the treatment of anorexia nervosa, bulimia and related clinical syndromes.
Claims12
A method of treating anorexia nervosa, bulimia and related clinical syndromes by administering eicosapentaenoic acid (EPA) in any appropriate form which can be assimilated by the body.
Use of eicosapentaenoic acid (EPA) in any appropriate form which can be assimilated by the body in the manufacture of a medicament for the treatment of anorexia nervosa, bulimia and related clinical syndromes.
Dependencies are inferred from the claim text.